Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Lumos Diagnostics Holdings Limited
  6. News
  7. Summary
    LDX   AU0000157091

LUMOS DIAGNOSTICS HOLDINGS LIMITED

(LDX)
  Report
Delayed Australian Stock Exchange  -  05/16 10:23:19 pm EDT
0.2800 AUD   -1.75%
04/10Lumos Diagnostics Holdings Limited Announces Appoints Rob Sambursky to the Role of Chief Medical Officer
CI
04/10Lumos Diagnostics Announces Appointment of Current Executive Chair Sam Lanyon as Interim CEO
CI
03/31LUMOS DIAGNOSTICS : Notification regarding unquoted securities - LDX
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lumos Diagnostics Launches Respiratory Infection Test in Liverpool, UK

01/11/2022 | 09:52pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
LUMOS DIAGNOSTICS HOLDINGS LIMITED -5.00% 0.28 Delayed Quote.-71.36%
ON SEMICONDUCTOR CORPORATION -1.83% 55.15 Delayed Quote.-18.80%
All news about LUMOS DIAGNOSTICS HOLDINGS LIMITED
04/10Lumos Diagnostics Holdings Limited Announces Appoints Rob Sambursky to the Role of Chie..
CI
04/10Lumos Diagnostics Announces Appointment of Current Executive Chair Sam Lanyon as Interi..
CI
03/31LUMOS DIAGNOSTICS : Notification regarding unquoted securities - LDX
PU
02/27LUMOS DIAGNOSTICS : FY2022 Half Year Update
PU
02/27Lumos Diagnostics Announces That It Received Market Authorization for the FebriDx® Test..
CI
02/27LUMOS DIAGNOSTICS : Appendix 4D and Half Year Report
PU
02/27Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended Dec..
CI
02/15Lumos Diagnostics Names New CFO; Shares Decline 6%
MT
02/15Lumos Diagnostics Announces Appointment of Barrie Lambert as Chief Financial Officer fo..
CI
02/10Lumos Diagnostics Holdings Limited Resignation Rob Sambursky from its Board
CI
More news
Financials
Sales 2022 20,5 M 14,2 M 14,2 M
Net income 2022 -19,1 M -13,2 M -13,2 M
Net cash 2022 30,8 M 21,3 M 21,3 M
P/E ratio 2022 -2,27x
Yield 2022 -
Capitalization 43,0 M 29,7 M 29,7 M
EV / Sales 2022 0,59x
EV / Sales 2023 0,56x
Nbr of Employees -
Free-Float 56,8%
Chart LUMOS DIAGNOSTICS HOLDINGS LIMITED
Duration : Period :
Lumos Diagnostics Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,29 AUD
Average target price 0,63 AUD
Spread / Average Target 119%
EPS Revisions
Managers and Directors
Sam Lanyon Executive Chairman & Chief Executive Officer
Barrie Lambert Chief Financial Officer
Robert P. Sambursky Chief Medical Officer
Sacha Dopheide Chief Technology Officer
Jeffrey Bishop SVP-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
LUMOS DIAGNOSTICS HOLDINGS LIMITED-71.36%31
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.10.83%22 407
BIOMÉRIEUX-29.13%10 895
DIASORIN S.P.A.-28.87%6 788
10X GENOMICS, INC.-68.03%5 400
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.-7.20%4 886